24 Jun 2026
Moving the Needle in Medicine:Heart Failure, Human Connection, and Career Fulfillment, With Anu Lala, MD
The advanced heart failure and transplant workforce faces a measurable recruitment deficit, driven less by competition from critical care subspecialties than by how and when trainees encounter the field during their formation.
In this episode of Moving the Needle in Medicine (https://www.hcplive.com/podcasts/moving-the-needle-podcast), host Dr. Alex Hajduczok, MD, a cardiologist and heart failure specialist at Oklahoma Heart Institute, sits down with Dr. Anu Lala, director of the Heart Failure Clinical Trials program and program director of the ACGME Fellowship in Advanced Heart Failure and Transplant at Mount Sinai Hospital, as well as a professor of medicine, cardiology, and population health science policy at the Mount Sinai Health System, to explore the personal experiences, mentors, and defining decisions that shaped her career in cardiovascular medicine.
Lala reflects on her upbringing in a close-knit Indian American family, emphasizing the influence of family, spirituality, and human connection on both her personal development and professional philosophy. She recounts a pivotal childhood experience caring for her grandmother during an acute myocardial infarction under the guidance of her father, a cardiologist, describing how that moment sparked her fascination with cardiovascular medicine and left a lasting impression on her understanding of service, healing, and patient care.
Lala then traces her educational and training journey through Johns Hopkins University, Rutgers Medical School, Mount Sinai, NYU, and Brigham and Women’s Hospital, highlighting the mentors and experiences that reinforced her commitment to advanced heart failure and transplantation. She discusses the unique aspects of the specialty that continue to inspire her, including the opportunity to care for patients during some of the most vulnerable periods of their lives. Beyond the field’s technical complexities, including hemodynamics, mechanical circulatory support, transplantation, and rapidly evolving therapeutics, Lala emphasizes that heart failure medicine is fundamentally about understanding patients’ motivations, values, and purpose. She also reflects on the profound impact of her first transplant procurement and implantation experience, describing transplantation as a powerful reminder of the shared humanity that transcends race, culture, and personal background.
The discussion turns to workforce development and the ongoing challenge of recruiting trainees into advanced heart failure. Lala argues that many learners are exposed primarily to the specialty’s most demanding inpatient settings, where physicians are caring for critically ill patients under significant stress. She suggests that this narrow exposure often fails to capture the longitudinal successes that define much of heart failure practice, including patients thriving after transplantation or ventricular assist device implantation. Both speakers emphasize the need for broader trainee experiences that highlight outpatient care, procedural opportunities, long-term patient relationships, and the rewarding outcomes made possible by modern heart failure therapies. They also discuss structural challenges facing the field, including reimbursement disparities and the increasing complexity of multidisciplinary care.
The conversation further explores Lala’s transition from fellowship to faculty leadership, including the challenges of navigating early career decisions, balancing personal and professional responsibilities, and identifying the right institutional fit. She shares lessons learned from her move to Mount Sinai, where she built a growing heart failure and transplant clinical trials program, expanded research infrastructure, and developed a strong commitment to mentorship and education. Lala highlights the importance of leadership development, institutional support, and self-reflection, encouraging early-career physicians to remain flexible and recognize that career paths often evolve over time.
The episode concludes with a discussion of Lala’s leadership within the heart failure community, including her role with the Journal of Cardiac Failure. She describes the journal’s evolution into a platform focused not only on scientific excellence but also on mentorship, collaboration, and community building. Throughout the conversation, Lala underscores the importance of authenticity, shared leadership, lifelong mentorship, and meaningful relationships, encouraging listeners to define success not by titles or achievements alone, but by their ability to positively influence patients, colleagues, and the future of the field.
Editors’ Note: Hajduczok reports disclosures with Impulse Dynamics, Edwards Lifesciences, and Corstasis. Lala reports disclosures with Abiomed, AstraZeneca, Merck & Co., Novo Nordisk, Sequana, Bayer, and others.
